SBIR Topic 412: VivoSense Cancer Health Informatics Platform, Phase I

NIH RePORTER · NIH · N43 · $392,519 · view on reporter.nih.gov ↗

Abstract

The overarching goal of Vivonoetics, Inc. is to develop a scalable informatics platform to conduct advanced physiological monitoring and processing of data from wearable sensors. The proposed software will perform advanced analytics for early detection, continuous assessment of disease progression and treatment sideeffects, patient centric treatment plans and decentralized data capture in cancer drug trials. In this Phase I feasibility project, Vivonoetics, Inc. will engage experts in the fields of cancer research and care to conceptualize, design and build a working prototype.

Key facts

NIH application ID
10265750
Project number
75N91020C00058-0-9999-1
Recipient
VIVOSENSE, INC.
Principal Investigator
Kate Lyden
Activity code
N43
Funding institute
NIH
Fiscal year
2020
Award amount
$392,519
Award type
Project period
2020-09-16 → 2021-06-15